ReviewJournal of cannabis research2024
An emerging trend in Novel Psychoactive Substances (NPSs): designer THC.
Review in Journal of cannabis research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cannabis use among Arab students: a systematic review.Frontiers in psychiatry · 2025Pooled it
- Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026Review
- Preliminary pharmacokinetic investigations of hydroxylated metabolites after controlled inhalative and oral consumption of hexahydrocannabinol (HHC).Scientific reports · 2026Article
- Rapid LC-QTOF-MS screening method for semi-synthetic cannabinoids in whole blood.Journal of analytical toxicology · 2026Article
- Cannabinoid Vaping Products: Regulation, Composition, Toxicological Effects, and Emerging Research.Chemical research in toxicology · 2025Review
- Outsmarting generic legislation: 4 years into the cat-and-mouse game of the synthetic cannabinoid receptor agonist market since the Chinese ban in 2021.Archives of toxicology · 2025Review
- Identification of Tetrahydrocannabidiol Metabolites in Human Urine.Drug testing and analysis · 2025Article
- Chemometric Optimization of BFChemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Ultra-high sensitive MSPE-UPLC-MS/MS method based on magnetic nanoparticles for the detection of synthetic cannabinoids in wastewater.Mikrochimica acta · 2025Article
- Identification of Three Novel Tetrahydrocannabinol Analogs in the European Market.Drug testing and analysis · 2025Article
- Prolonged sedation and unconsciousness after intoxication with the novel semisynthetic cannabinoid hexahydrocannabioctyl (HHC-C8): Two case descriptions.Toxicology reports · 2025Article
- Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets.Journal of natural products · 2025Article
- Chromatographic and Spectroscopic Analyses of Cannabinoids: A Narrative Review Focused on Cannabis Herbs and Oily Products.Molecules (Basel, Switzerland) · 2025Review
- Correction: Competing Interests.Journal of cannabis research · 2025Article
- "Non-Flavor" Flavors: What Are the Implications of Derived Psychoactive Cannabis Product Marketing?Journal of studies on alcohol and drugs · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since its discovery as one of the main components of cannabis and its affinity towards the cannabinoid receptor CB1, serving as a means to exert its psychoactivity, Δ
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.